0
     

Report Added
Report already added
Analgesics in Chile

Analgesics in Chile

Following 2021’s dynamic performance, acetaminophen (both adult and paediatric) continues to enjoy healthy growth in 2022. Positive sales continue to be linked to recommendations by the country's health authorities as a suitable analgesic for the treatment of COVID-19 symptoms in addition to being effective at mitigating the effects of the vaccine. Acetaminophen is therefore highly trusted by the local population as a safe and effective remedy in addition to being stocked at home in anticipation...

Euromonitor International's Analgesics in Chile report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Analgesics in Chile

List Of Contents And Tables

ANALGESICS IN CHILE
KEY DATA FINDINGS
2022 DEVELOPMENTS
Further growth for acetaminophen in 2022 underpinned by being most recommended analgesic to treat COVID-19 symptoms
Further strong declines for aspirin in 2022 due to increasing perception as limited suitability for those suffering from heart conditions
Laboratorio Chile to gain leadership of analgesics in 2022, with Bayer relying on aspirin
Greater awareness of active ingredients benefits bioequivalents and generics
PROSPECTS AND OPPORTUNITIES
Competitive pricing and promoting private label will be used by companies as strategies to strengthen position in category
Genomma Lab to boost its presence in Chilean analgesics from 2022
Herbal/traditional products expected to rise as preferred alternative
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2017-2022
Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN CHILE
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Report Title: Analgesics in Chile


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW